Inhibition of the Nogo-pathway in Experimental Spinal Cord Injury: a Meta-analysis of 76 Experimental Treatments

Overview

Journal Sci Rep

Specialty Science

Date 2023 Dec 21

PMID 38129508

Authors

Julian Hirt

Alireza Khanteymoori

Marc Hohenhaus

Marcel A Kopp

David W Howells

Jan M Schwab

Ralf Watzlawick

Affiliations

Soon will be listed here.

Abstract

Recovery after spinal cord injury (SCI) may be propagated by plasticity-enhancing treatments. The myelin-associated nerve outgrowth inhibitor Nogo-A (Reticulon 4, RTN4) pathway has been shown to restrict neuroaxonal plasticity in experimental SCI models. Early randomized controlled trials are underway to investigate the effect of Nogo-A/Nogo-Receptor (NgR1) pathway blockers. This systematic review and meta-analysis of therapeutic approaches blocking the Nogo-A pathway interrogated the efficacy of functional locomotor recovery after experimental SCI according to a pre-registered study protocol. A total of 51 manuscripts reporting 76 experiments in 1572 animals were identified for meta-analysis. Overall, a neurobehavioral improvement by 18.9% (95% CI 14.5-23.2) was observed. Subgroup analysis (40 experiments, N = 890) revealed SCI-modelling factors associated with outcome variability. Lack of reported randomization and smaller group sizes were associated with larger effect sizes. Delayed treatment start was associated with lower effect sizes. Trim and Fill assessment as well as Egger regression suggested the presence of publication bias. Factoring in theoretically missing studies resulted in a reduced effect size [8.8% (95% CI 2.6-14.9)]. The available data indicates that inhibition of the Nogo-A/NgR1pathway alters functional recovery after SCI in animal studies although substantial differences appear for the applied injury mechanisms and other study details. Mirroring other SCI interventions assessed earlier we identify similar factors associated with outcome heterogeneity.

References

Stern S, Hilton B, Burnside E, Dupraz S, Handley E, Gonyer J . RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury. Neuron. 2021; 109(21):3436-3455.e9. DOI: 10.1016/j.neuron.2021.08.014. View

Schwab M . Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 2010; 11(12):799-811. DOI: 10.1038/nrn2936. View

Geoffroy C, Zheng B . Myelin-associated inhibitors in axonal growth after CNS injury. Curr Opin Neurobiol. 2014; 27:31-8. PMC: 4122599. DOI: 10.1016/j.conb.2014.02.012. View

Kullander K, Butt S, Lebret J, Lundfald L, Restrepo C, Rydstrom A . Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science. 2003; 299(5614):1889-92. DOI: 10.1126/science.1079641. View

Page M, Sterne J, Higgins J, Egger M . Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: A review. Res Synth Methods. 2020; 12(2):248-259. DOI: 10.1002/jrsm.1468. View

Schwab M, Strittmatter S . Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol. 2014; 27:53-60. PMC: 4122629. DOI: 10.1016/j.conb.2014.02.011. View

Wang K, Koprivica V, Kim J, Sivasankaran R, Guo Y, Neve R . Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002; 417(6892):941-4. DOI: 10.1038/nature00867. View

Matsunaga E, Tauszig-Delamasure S, Monnier P, Mueller B, Strittmatter S, Mehlen P . RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol. 2004; 6(8):749-55. DOI: 10.1038/ncb1157. View

Kopp M, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing G . Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res. 2012; 349(1):119-32. PMC: 3744771. DOI: 10.1007/s00441-012-1334-7. View

10.

Yiu G, He Z . Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006; 7(8):617-27. PMC: 2693386. DOI: 10.1038/nrn1956. View

11.

Caroni P, Schwab M . Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol. 1988; 106(4):1281-8. PMC: 2115009. DOI: 10.1083/jcb.106.4.1281. View

12.

Acevedo L, Yu J, Erdjument-Bromage H, Miao R, Kim J, Fulton D . A new role for Nogo as a regulator of vascular remodeling. Nat Med. 2004; 10(4):382-8. DOI: 10.1038/nm1020. View

13.

Kempf A, Tews B, Arzt M, Weinmann O, Obermair F, Pernet V . The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. PLoS Biol. 2014; 12(1):e1001763. PMC: 3891622. DOI: 10.1371/journal.pbio.1001763. View

14.

Ferguson A, Hook M, Garcia G, Bresnahan J, Beattie M, Grau J . A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury. J Neurotrauma. 2005; 21(11):1601-13. DOI: 10.1089/neu.2004.21.1601. View

15.

Fouad K, Ng C, Basso D . Behavioral testing in animal models of spinal cord injury. Exp Neurol. 2020; 333:113410. PMC: 8325780. DOI: 10.1016/j.expneurol.2020.113410. View

16.

Park J, Yiu G, Kaneko S, Wang J, Chang J, He X . A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron. 2005; 45(3):345-51. DOI: 10.1016/j.neuron.2004.12.040. View

17.

Kottis V, Thibault P, Mikol D, Xiao Z, Zhang R, Dergham P . Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem. 2002; 82(6):1566-9. DOI: 10.1046/j.1471-4159.2002.01146.x. View

18.

Sena E, Currie G, McCann S, Macleod M, Howells D . Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab. 2014; 34(5):737-42. PMC: 4013765. DOI: 10.1038/jcbfm.2014.28. View

19.

Chen M, Huber A, van der Haar M, Frank M, Schnell L, Spillmann A . Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000; 403(6768):434-9. DOI: 10.1038/35000219. View

20.

Giger R, Hollis 2nd E, Tuszynski M . Guidance molecules in axon regeneration. Cold Spring Harb Perspect Biol. 2010; 2(7):a001867. PMC: 2890195. DOI: 10.1101/cshperspect.a001867. View